AUS
NZ
UK
CA
USA
IND
Highlights
- Quadrise Plc (QED) stock rose by 11.3% on Thursday.
- The company’s stock traded at a high of GBX 3.89, up from a previous close of GBX 3.42.
- Trading volume fell 51%, with 2.3 million shares exchanged compared to an average of 4.7 million.
Quadrise Plc (LON:QED), a company specializing in emulsion fuels, experienced an impressive 11.3% rise in its share price on Thursday. The stock surged to a high of GBX 3.89 before settling at GBX 3.81, surpassing the previous closing value of GBX 3.42. Despite the strong price movement, the volume of shares traded was notably lower, with 2.3 million shares changing hands. This was a sharp decrease from the average daily volume of 4.7 million shares, suggesting that the increase in price was driven by less activity, but possibly more concentrated investor interest.
Quadrise is focused on developing and marketing alternative fuel solutions, specifically designed for power generation, industrial applications, marine diesel engines, and steam generation. The company's proprietary technologies, including the Multiphase Superfine Atomised Residue (MSAR) technology and bioMSAR technology, offer oil-in-water emulsion-based fuels as replacements for conventional heavy fuel oil and biofuels, respectively. These technologies are aimed at providing a more efficient and environmentally friendly solution for energy production.
The increase in Quadrise’s stock price comes as the company continues to make strides in its niche sector, offering sustainable and cost-effective fuel alternatives. Although the trading volume was significantly lower than average, the price uptick indicates that there may be growing confidence in the company's potential, driven by its technological advancements and growing market recognition in the energy and marine industries.
With the stock reaching new highs, attention remains on Quadrise’s ability to capitalize on its fuel technologies and expand its footprint in an increasingly competitive energy market. The continued development of MSAR and bioMSAR could play a key role in the company's future performance.
